NIH recombinant DNA Advisory Committee continues to ponder adverse event associated with AAV gene therapy trial.
Williams DA; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2008, vol. 16, issue 3, p 427, ISSN 15250024. ISBN 15250024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef